Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Apr;241(4):629-39.
doi: 10.1097/01.sla.0000157272.04803.1b.

Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey

Affiliations
Comparative Study

Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey

Alphonse Taghian et al. Ann Surg. 2005 Apr.

Abstract

Objective: The surgical margin status after breast-conserving surgery is considered the strongest predictor for local failure. The purpose of this study is to survey how radiation oncologists in North America (NA) and Europe define negative or close surgical margins after lumpectomy and to determine the factors that govern the decision to recommend reexcision based on the margins status.

Methods: A questionnaire was sent to active members of the European Society of Therapeutic Radiation Oncology and the American Society for Therapeutic Radiology and Oncology who had completed training in radiation oncology. Respondents were asked whether they would characterize margins to be negative or close for a variety of scenarios. A second survey was sent to 500 randomly selected radiation oncologists in the United States to assess when a reexcision would be recommended based on surgical margins.

Results: A total of 702 responses were obtained from NA and 431 from Europe to the initial survey. An additional 130 responses were obtained from the United States to the second survey regarding reexcision recommendations. Nearly 46% of the North American respondents required only that there be "no tumor cells on the ink" to deem a margin negative (National Surgical Adjuvant Breast and Bowel Project definition). A total of 7.4% and 21.8% required no tumor cells seen at <1 mm and <2 mm, respectively. The corresponding numbers from European respondents were 27.6%, 11.2%, and 8.8%, respectively (P <0.001). Europeans more frequently required a larger distance (>5 mm) between tumor cells and the inked edges before considering a margin to be negative.

Conclusion: This study revealed significant variation in the perception of negative and close margins among radiation oncologists in NA and Europe. Given these findings, a universal definition of negative margins and consistent recommendations for reexcision are needed.

PubMed Disclaimer

Figures

None
FIGURE 1. Responses regarding the definition of negative margins in North America (United States and Canada). Results from 702 respondents. The question asked was: “How do you define negative margins after local excision?”
None
FIGURE 2. Responses regarding the definition of negative margins (comparison between North America and Europe). The question asked was: “How do you define negative margins after local excision?”
None
FIGURE 3. Responses regarding the definition of close margins (comparison between North America and Europe). The question asked was: “How do you define close margins after local excision?” All options had “no tumor cells are seen on the ink margins.” NA, North America, including the United States and Canada.

Comment in

Similar articles

Cited by

References

    1. National Institutes of Health Consensus Development Panel Consensus Statement. Treatment of early-stage breast cancer. J Natl Cancer Inst Monogr. 1992;11:11–15. - PubMed
    1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241. - PubMed
    1. Jacobson J, Danforth D, Cowan K, et al. Ten-year results of the National Cancer Institute's randomized trial of breast conservation versus mastectomy for stage I and II breast cancer. N Engl J Med. 1995;332:907–911. - PubMed
    1. van Dongen J, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–1150. - PubMed
    1. Blichert-Toft M, Rose C, Anderson JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life table analysis. J Natl Cancer Inst Monogr. 1992;11:19–26. - PubMed

Publication types

MeSH terms